SBI Healthcare Opportunities Fund vs Tata India Innovation Fund
Direct Plan, Growth option · Data as on 30-10-2026
SBI Healthcare Opportunities Fund is a Thematic fund and Tata India Innovation Fund is a Thematic fund. In the year to 30-10-2026, SBI Healthcare Opportunities Fund (Direct) returned 17.1% and Tata India Innovation Fund (Direct) returned −1.9%. SBI Healthcare Opportunities Fund charges 1.01% a year and Tata India Innovation Fund 0.97% (Direct plans). Their portfolios overlap 10.3%: they hold 9 of the same securities.
SBI Healthcare Opportunities Fund
Thematic
- 1 year return
- 17.1%
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Tata India Innovation Fund
Thematic
- 1 year return
- −1.9%
- Expense ratio
- 0.97%
- NAV
- ₹10.02
Which is better, SBI Healthcare Opportunities or Tata India Innovation? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- SBI Healthcare Opportunities returned more over 1 year: 17.1% against −1.9%.
- Tata India Innovation costs less: 0.97% a year against 1.01% (Direct plans).
- SBI Healthcare Opportunities fell less in its worst fall since 05-12-2024: −13.5% against −18.1%.
- Tata India Innovation holds more in large companies: 42.6% of the fund in large caps against 32.3%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹1,245 Cr.
- Their portfolios overlap 10.3%: 9 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | SBI Healthcare Opportunities Fund | Tata India Innovation Fund |
|---|---|---|
| Fund house | SBI Mutual Fund | Tata Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹5,870 Cr (30-09-2026) | ₹1,245 Cr (30-09-2026) |
| NAV | ₹588.16 (Direct) | ₹10.02 (Direct) |
| Expense ratio (Direct) | 1.01% | 0.97% |
| Expense ratio (Regular) | 1.99% | 2.37% |
| Riskometer | Not available | Very High |
| Benchmark | Not available | Nifty 500 TRI |
| Launch date | Not available | 28-11-2024 |
| Minimum investment | Not available | ₹5,000 |
| Lock in | Not available | None |
| Fund managers | Not available | Meeta Shetty, Hasmukh Vishariya |
| Exit load | Not available | Exit load of 0.50%, if redeemed within 30 days. |
SBI Healthcare Opportunities vs Tata India Innovation: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| Tata India Innovation Fund (Direct) | −0.27% | −3.35% | +6.88% | −1.91% | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | -- | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
SBI Healthcare Opportunities vs Tata India Innovation: Year-wise Returns
| Year | SBI Healthcare OpportunitiesSBI Healthcare Opportunities | Tata India InnovationTata India Innovation |
|---|---|---|
| 2026to date | +21.31% | −0.43% |
| 2025 | −2.50% | −0.34% |
| 2024 | +43.75% | -- |
| 2023 | +39.72% | -- |
| 2022 | −5.01% | -- |
| 2021 | +21.48% | -- |
SBI Healthcare Opportunities vs Tata India Innovation: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of SBI Healthcare Opportunities Fund
Rolling returns
Every 1-year holding period, 224 of them, one for each trading day from 05-12-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
SBI Healthcare Opportunities Fund (Direct)
Tata India Innovation Fund (Direct)
BSE Healthcare TRI
to
Dec 2025Feb 2025
to
Feb 2026Apr 2025
to
Apr 2026Jun 2025
to
Jun 2026Aug 2025
to
Aug 2026Oct 2025
to
Oct 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities | 15.2 | 12.9 | 15.6 | 22.3 | 17.4 | 16.1 | 0.4 | 10.5% | 11.2% | −3.3% | 25.3% | 68% |
| Tata India Innovation | 23.1 | 54.3 | 22.6 | 0.0 | 0.0 | 0.0 | 0.0 | 2.6% | 2.6% | −5.5% | 9.7% | 19% |
| BSE Healthcare TRI | 15.2 | 14.3 | 20.1 | 35.7 | 14.7 | 0.0 | 0.0 | 8.6% | 10.1% | −3.7% | 19.5% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 05-12-2024. Past returns do not promise future returns.
SBI Healthcare Opportunities vs Tata India Innovation: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 02-12-2024 to 30-10-2026: 23 instalments, ₹2,30,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct) | ₹2,30,000 | ₹2,69,986 | ₹39,986 | 17.1% |
| Tata India InnovationTata India Innovation Fund (Direct) | ₹2,30,000 | ₹2,37,913 | ₹7,913 | 3.4% |
SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct)
Tata India InnovationTata India Innovation Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
SBI Healthcare Opportunities vs Tata India Innovation: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | SBI Healthcare Opportunities Fund (Direct) | Tata India Innovation Fund (Direct) |
|---|---|---|
| Return (CAGR) | +17.12% | −1.91% |
| Standard deviation | 13.36% | 14.35% |
| Sharpe ratio | 0.89 | -0.50 |
| Sortino ratio | 1.33 | -0.68 |
| Maximum drawdown | −10.3% (23-10-2026) | −16.8% (23-03-2026) |
| Beta | 0.93 | 0.95 |
| Alpha | +5.25% | +4.76% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | SBI Healthcare Opportunities Fund (Direct) | Tata India Innovation Fund (Direct) |
|---|---|---|
| Return (CAGR) | +17.93% | −0.65% |
| Standard deviation | 15.96% | 14.70% |
| Sharpe ratio | 0.74 | -0.42 |
| Sortino ratio | 1.05 | -0.57 |
| Maximum drawdown | −30.5% (23-03-2020) | −18.1% (07-04-2025) |
| Beta | 0.91 | 0.98 |
| Alpha | +3.97% | +1.43% |
From daily NAVs, 02-01-2013 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
SBI Healthcare Opportunities Fund (Direct)
Tata India Innovation Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | −13.5% | 07-01-2025 | 28-02-2025 | 17-07-2025 | 5 months | −3.8% |
| Tata India Innovation Fund (Direct) | −18.1% | 02-01-2025 | 07-04-2025 | 19-09-2025 | 5 months | −5.5% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 05-12-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
SBI Healthcare Opportunities Fund (Direct)
Tata India Innovation Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| SBI Healthcare Opportunities Fund (Direct) | 100% | 86% | 3.80% |
| Tata India Innovation Fund (Direct) | 74% | 97% | 9.72% |
From month-end values since 05-12-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
SBI Healthcare Opportunities vs Tata India Innovation: Portfolio Overlap
From each fund's latest monthly portfolio: SBI Healthcare Opportunities Fund, September 2026; Tata India Innovation Fund, September 2026
Holdings in common
- Overlap
- 10.3%
- Held by both
- 9
- Only in SBI Healthcare Opportunities
- 27
- Only in Tata India Innovation
- 51
| Security | % of SBI Healthcare Opportunities | % of Tata India Innovation |
|---|---|---|
| Dr. Lal Path labs Ltd. | 1.62% | 2.73% |
| Acutaas Chemicals Ltd. | 5.03% | 1.45% |
| Sai Life Sciences Ltd. | 2.60% | 1.40% |
| Healthcare Global Enterprises Ltd. | 1.70% | 1.27% |
| Aster DM Quality Care Ltd. | 3.21% | 1.10% |
| Torrent Pharmaceuticals Ltd. | 4.42% | 1.08% |
| Aurobindo Pharma Ltd. | 3.42% | 1.07% |
| Syngene International Ltd. | 1.12% | 0.81% |
| Rainbow Children's Medicare Ltd. | 0.67% | 0.53% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 10.3% means 10.3% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.14% |
| Divi's Laboratories Ltd. | 7.91% |
| Apollo Hospitals Enterprise Ltd. | 4.45% |
| Cipla Ltd. | 4.40% |
| Laurus Labs Ltd. | 4.05% |
Largest holdings only in Tata India Innovation Fund
| Security | % of fund |
|---|---|
| ICICI BANK LTD | 5.07% |
| HDFC BANK LTD | 4.13% |
| ADANI PORTS AND SPECIAL ECONOMIC ZONE LTD | 3.74% |
| RELIANCE INDUSTRIES LTD | 3.50% |
| AXIS BANK LTD | 3.41% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | SBI Healthcare Opportunities | Tata India Innovation |
|---|---|---|
| Equity | 95.5% | 91.6% |
| Debt | 0.1% | 0.0% |
| Cash and others | 4.4% | 8.4% |
Market cap of stocks
| Market cap | SBI Healthcare Opportunities | Tata India Innovation |
|---|---|---|
| Large Cap | 32.3% | 42.6% |
| Mid Cap | 25.7% | 13.4% |
| Small Cap | 35.4% | 33.3% |
| Not on AMFI's list | 2.2% | 2.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | SBI Healthcare Opportunities | Tata India Innovation |
|---|---|---|
| Pharmaceuticals & Biotechnology | 63.1% | 7.8% |
| Healthcare Services | 25.6% | 10.5% |
| Banks | 0.0% | 17.9% |
| Retailing | 0.0% | 7.0% |
| Auto Components | 0.0% | 6.6% |
| Automobiles | 0.0% | 6.5% |
| Chemicals & Petrochemicals | 5.0% | 2.6% |
| Healthcare Equipment & Supplies | 1.8% | 0.1% |
The six largest sectors of each fund's stocks, % of the fund.
SBI Healthcare Opportunities vs Tata India Innovation: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | SBI Healthcare Opportunities Fund | Tata India Innovation Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.01% | 0.97% |
| Base expense ratio (Direct) | 0.74% | 0.66% |
| Total expense ratio (Regular) | 1.99% | 2.37% |
| Base expense ratio (Regular) | 1.58% | 1.86% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare SBI Healthcare Opportunities with
SBI Healthcare Opportunities Fund vs Tata India Innovation Fund: Frequently Asked Questions
What is the difference between SBI Healthcare Opportunities Fund and Tata India Innovation Fund?
SBI Healthcare Opportunities Fund is a Thematic fund, Tata India Innovation Fund is a Thematic fund, run by SBI Mutual Fund and Tata Mutual Fund. Their portfolios overlap 10.3%. SBI Healthcare Opportunities Fund charges 1.01% a year and Tata India Innovation Fund 0.97%.
Which has given higher returns, SBI Healthcare Opportunities Fund or Tata India Innovation Fund?
Over 1 year: SBI Healthcare Opportunities Fund +17.12%, Tata India Innovation Fund −1.91%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, SBI Healthcare Opportunities Fund or Tata India Innovation Fund?
Tata India Innovation Fund charges less: 0.97% a year against 1.01%. These are the Direct plans' total expense ratios reported to AMFI.
How much do SBI Healthcare Opportunities Fund and Tata India Innovation Fund overlap?
10.3%. They hold 9 of the same securities, the largest shared ones being LALPATHLAB, ACUTAAS, SAILIFE. From each fund's latest monthly portfolio.
Can I invest in both SBI Healthcare Opportunities Fund and Tata India Innovation Fund?
Yes. 10.3% of each fund's money sits in the same holdings, so some of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.